KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Upgrade: 31 Kovera certificates.
The lab's record shows 31 certificates printed for Upgrade, analysed between 6 Mar 2026 and 13 May 2026, covering 23 products. Median HPLC purity is 99.89%. Kovera graded 31 as a pass and 0 as a fail.
31
certificates
99.89%
median purity
23
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 31 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 12 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
23 AS PRINTEDRetatrutide · 4BPC-157 · 2BPC-157/TB-500 · 2GHK-Cu · 2Klow · 2Tesamorelin · 2AOD-9604 · 1ARA-290 · 1Cartalax · 1CJC-1295 (No DAC)/Ipamorelin · 1DSIP · 1Epithalon · 1Glow · 1KPV · 1Melanotan-2 · 1MOTS-c · 1NAD+ · 1Pinealon · 1PT-141 · 1Sermorelin · 1SS-31 · 1Tesamorelin/Ipamorelin · 1Thymosin alpha-1 · 1
Every certificate
NEWEST FIRST · 31 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-FBC0D1 | BPC-157 | 70-202605-06 | 99.856% | 114.6%11.46 of 10 mg | 13 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-F08C42 | PT-141 | 70-202604-34 | 99.838% | 117.6%11.76 of 10 mg | 13 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-CF4E2A | Cartalax | 70-202604-92 | 99.972% | 117.8%23.56 of 20 mg | 13 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-7905C1 | SS-31 | 70-202604-68 | 99.986% | 97.4%9.74 of 10 mg | 13 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-632E0D | Retatrutide | 70-202605-35 | 99.909% | 109.8%10.98 of 10 mg | 13 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-A54A8D | Sermorelin | 70-202505-45 | 99.886% | 110.6%5.53 of 5 mg | 11 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-8F0958 | Pinealon | 70-202604-71 | 99.802% | 109.4%21.88 of 20 mg | 11 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-89073F | Klow | 70-202605-20 | 99.708% | 105.1%84.05 of 80 mg | 11 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-28888C | DSIP | 70-202604-12 | 99.864% | 110.6%5.53 of 5 mg | 11 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-0DAB85 | MOTS-c | 70-202605-29 | 99.854% | 109.1%10.91 of 10 mg | 11 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-FA2B20 | Klow | 70-202604-20 | 99.641% | 105.3%84.23 of 80 mg | 21 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-F32A52 | KPV | 70-202604-22 | 99.957% | 92.2%9.22 of 10 mg | 21 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-E0FB6F | GHK-Cu | 70-202604-14 | 99.944% | 111.6%55.81 of 50 mg | 21 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B6045F | CJC-1295 (No DAC)/Ipamorelin | 70-202604-09 | 99.591% | 116.1%11.61 of 10 mg | 21 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-723179 | Melanotan-2 | 70-202604-28 | 99.853% | 111.2%11.12 of 10 mg | 21 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-6529C8 | AOD-9604 | 70-202604-01 | 99.946% | 118.4%5.92 of 5 mg | 21 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-61FDDB | Tesamorelin | 70-202603-54 | 99.858% | 106.1%10.61 of 10 mg | 21 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-067160 | ARA-290 | 70-202604-66 | 99.891% | 98.3%9.83 of 10 mg | 21 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-FC4AAB | Retatrutide | 70-202604-37 | 99.978% | 97.3%38.92 of 40 mg | 17 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-A9A282 | Tesamorelin/Ipamorelin | 70-202603-52 | 99.811% | 107.9%16.18 of 15 mg | 16 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-6B0379 | Retatrutide | 70-202604-36 | 99.807% | 116.7%23.34 of 20 mg | 12 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-AA9D0A | NAD+ | 20-202604-30 | 99.984% | 98.2%982.16 of 1000 mg | 7 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-C60AA8 | Tesamorelin | 70-202603-54 | 99.987% | 108.1%10.81 of 10 mg | 30 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-97982E | GHK-Cu | 70-202603-14 | 99.949% | 105.8%52.88 of 50 mg | 30 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-3892C6 | Epithalon | 70-202603-13 | 99.922% | 105.7%10.57 of 10 mg | 22 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-EE2BDA | BPC-157/TB-500 | 70-202603-04 | 99.838% | 105.9%10.59 of 10 mg | 14 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CDA30C | Thymosin alpha-1 | 70-202603-56 | 99.961% | 116.3%11.63 of 10 mg | 14 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-7873B5 | BPC-157/TB-500 | 70-202603-05 | 99.854% | 108.0%21.59 of 20 mg | 14 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-661DF2 | BPC-157 | 70-202603-06 | 99.961% | 112.6%11.26 of 10 mg | 14 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-06317C | Glow | 70-202603-16 | 99.691% | 103.1%72.14 of 70 mg | 14 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-CF299B | Retatrutide | 70-202603-35 | 99.962% | 105.7%10.57 of 10 mg | 6 Mar 2026 | PASS | Kovera ↗our verifier → |